Dupilumab Therapy in Nephrotic Syndrome in Children — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dupilumab Therapy in Nephrotic Syndrome in Children — Stella

Recruiting

Back to Nephrotic Syndrome in Children trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Singapore

National University Hospital, Singapore, Singapore

KK Women's and Children's Hospital, Singapore, Singapore

Key details

Phase

Safety & dosing

Sponsor

National University Hospital, Singapore

Collaborators

National Medical Research Council (NMRC), Singapore, KK Women's and Children's Hospital

Enrollment target

~66 participants

Started

November 2025

Primary completion

February 2028

Age range

6 Years – 18 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov